Seeking Alpha

  KaloBios Pharmaceuticals - NASDAQ

11/22/2014, 10:53 PM ET
  • Dmaddron | Send Message 4 Nov 2013

      KBIO vs. ETF Alternatives
      Company Description
      KaloBios Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of monoclonal antibody therapeutics for diseases that burdens the society and to patients and their families.